PCA3 and posterior cortical atrophy: Urine-based PCa tests approved for clinical use include the PCA3 (PROGENSA) test, which measures mRNA levels of PCA3, a non-coding PCa-specific gene, in post-digital rectal exam (post-DRE) urine specimens.